Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates
1st Nov 2005, 15:51 GMT
Ground-breaking results from researchers at Harvard Medical School and Massachusetts Institute of Technology (MIT), USA, disclosed at the 13th European Cancer Conference (ECCO) in Paris have shown for the first time that targeted drug delivery is possible using nanoparticle-apatamer conjugates.
Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates related news:
- Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates — KeralaNext: Latest News
- Researchers unveil reliable new approach to cancer drug delivery — Physics Org
- Research unveils new, reliable approach to drug delivery for cancer patients — EurekAlert! - Cancer
- Citizens' tips lead police to drug suspects — PittsburghLIVE.com
- Scene of Sydney shooting targeted before — NATIONAL
- Kerb-crawlers targeted in blitz on prostitution — Scotsman.com News - Prostitution
- BAE unit lands $10.5M delivery — Latest news from Boston Business Journal
- Kenya: Govt Will Not Protect Drug Makers — AllAfrica News: Health and Medicine
- Roche seeking others to make Tamiflu bird flu drug — Health News Online - Medical and health information and tools from Armenian Medical Network
- TNT 3rd quarter profit rises, helped by express — Business Times Online - All The Headlines
Latest news from News-Medical News Feed:
- Children being set up for heart disease later on in life
- New cancer treatments use body's own immune system to kill melanoma tumours
- IVF success compromised by heavy smoking
- Why we all carry on with those bad habits
- Sugar and fizzy drinks linked to pancreatic cancer
- SpectraScience files new patent application
- Global Patient Safety Challenge: Clean Care is Safer Care
- FDA strengthens program for medical devices
- Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer
- More U.S residents trust TV for health info